UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How can clinical trials expedite the process of answering treatment-related questions and reduce the number of participants needed?

European psychiatry, 2024-08, Vol.67 (S1), p.S38-S38

Emsley, R

2024

Volltextzugriff (PDF)

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1158-1166

2020

Volltextzugriff (PDF)

Social media and its relationship with mood, self‐esteem and paranoia in psychosis

Acta psychiatrica Scandinavica, 2018-12, Vol.138 (6), p.558-570

2018

Volltextzugriff (PDF)

C.06.01 The treatment continuum in schizophrenia from the acute phase to maintenance

European neuropsychopharmacology, 2015-09, Vol.25, p.S666-S667

Emsley, R

2015

Volltextzugriff (PDF)

C.12.01 The nature of relapse in schizophrenia

European neuropsychopharmacology, 2014-10, Vol.24, p.S762-S763

Emsley, R

2014

Volltextzugriff (PDF)

Routine hospital management of self-harm and risk of further self-harm: propensity score analysis using record-based cohort data

Psychological medicine, 2018-01, Vol.48 (2), p.315-326

2018

Volltextzugriff (PDF)

An experience sampling study of worry and rumination in psychosis

Psychological medicine, 2014-06, Vol.44 (8), p.1605-1614

2014

Volltextzugriff (PDF)

Psychotherapy of Biases in Cognition in Schizophrenia: the SlowMo Randomised Controlled Trial for Paranoia, Outcomes and Mechanisms

European psychiatry, 2022-06, Vol.65 (S1), p.S19-S20

2022

Volltextzugriff (PDF)

Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition

Psychological medicine, 2018-10, Vol.48 (13), p.2186-2193

2018

Volltextzugriff (PDF)

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

European neuropsychopharmacology, 2006-02, Vol.16 (2), p.93-100

2006

Volltextzugriff (PDF)

Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment

Psychological medicine, 2017-09, Vol.47 (12), p.2187-2196

2017

Volltextzugriff (PDF)

Sex versus gender associations with brain structure

Journal of clinical neuroscience, 2024-04, Vol.122, p.103-109

2024

Volltextzugriff (PDF)

Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning

Psychiatry research, 2023-10, Vol.328, p.115460-115460, Article 115460

2023

Volltextzugriff (PDF)

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

British journal of dermatology (1951), 2019-05, Vol.180 (5), p.1069-1076

2019

Volltextzugriff (PDF)

Fronto-limbic white matter fractional anisotropy and body mass index in first-episode schizophrenia spectrum disorder patients compared to healthy controls

Psychiatry research. Neuroimaging, 2020-11, Vol.305, p.111173-111173, Article 111173

2020

Volltextzugriff (PDF)

CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings

BMC psychiatry, 2024-02, Vol.24 (1), p.122-122, Article 122

2024

Volltextzugriff (PDF)

Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia

PloS one, 2017-01, Vol.12 (1), p.e0170178-e0170178

2017

Volltextzugriff (PDF)

The UK AVATAR 1 and 2 Trials for People with Distressing Voices – Findings and Learning from AVATAR1, and AVATAR2 Developments in Theory and Therapy

European psychiatry, 2022-06, Vol.65 (S1), p.S22-S23

2022

Volltextzugriff (PDF)

Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months

Schizophrenia research, 2019-04, Vol.206, p.171-176

2019

Volltextzugriff (PDF)

Cognitive performance during the first year of treatment in first-episode schizophrenia: a case–control study

Psychological medicine, 2015-10, Vol.45 (13), p.2873-2883

2015

Volltextzugriff (PDF)

Relapse in schizophrenia: The role of factors other than non-adherence to treatment

Early intervention in psychiatry, 2024-02, Vol.18 (9), p.710-719

2024

Volltextzugriff (PDF)

Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls

Schizophrenia research, 2021-05, Vol.231, p.13-21

2021

Volltextzugriff (PDF)

Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial

Psychological medicine, 2017-10, Vol.47 (13), p.2358-2368

2017

Volltextzugriff (PDF)

Risperidone in the Treatment of First-Episode Psychotic Patients: A Double-Blind Multicenter Study

Schizophrenia bulletin, 1999-01, Vol.25 (4), p.721-729

Emsley, R. A.

1999

Volltextzugriff (PDF)

Associations between BMI and brain structures involved in food intake regulation in first-episode schizophrenia spectrum disorders and healthy controls

Journal of psychiatric research, 2022-08, Vol.152, p.250-259

2022

Volltextzugriff (PDF)

1 – 25 von 691

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(609)
Mit Volltextzugriff
(570)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(414)
Life Sciences & Biomedicine
(286)
Humans
(243)
Psychiatry
(163)
Male
(156)
Female
(153)
Adult
(124)
Physical Sciences
(116)
Chemistry
(100)
Middle Aged
(98)
Biological And Medical Sciences
(96)
Medical Sciences
(90)
Schizophrenia
(85)
Physics
(70)
Neurosciences & Neurology
(60)
Psychology. Psychoanalysis. Psychiatry
(56)
Treatment Outcome
(52)
Aged
(48)
Chemistry, Physical
(48)
Adolescent
(46)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

How can clinical trials expedite the process of answering treatment-related questions and reduce the number of participants needed?

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

Social media and its relationship with mood, self‐esteem and paranoia in psychosis

C.06.01 The treatment continuum in schizophrenia from the acute phase to maintenance

C.12.01 The nature of relapse in schizophrenia

Routine hospital management of self-harm and risk of further self-harm: propensity score analysis using record-based cohort data

An experience sampling study of worry and rumination in psychosis

Psychotherapy of Biases in Cognition in Schizophrenia: the SlowMo Randomised Controlled Trial for Paranoia, Outcomes and Mechanisms

Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment

Sex versus gender associations with brain structure

Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

Fronto-limbic white matter fractional anisotropy and body mass index in first-episode schizophrenia spectrum disorder patients compared to healthy controls

CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings

Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia

The UK AVATAR 1 and 2 Trials for People with Distressing Voices – Findings and Learning from AVATAR1, and AVATAR2 Developments in Theory and Therapy

Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months

Cognitive performance during the first year of treatment in first-episode schizophrenia: a case–control study

Relapse in schizophrenia: The role of factors other than non-adherence to treatment

Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls

Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial

Risperidone in the Treatment of First-Episode Psychotic Patients: A Double-Blind Multicenter Study

Associations between BMI and brain structures involved in food intake regulation in first-episode schizophrenia spectrum disorders and healthy controls

Suchergebnisse filtern